|Articles|August 1, 2002

Adamis on board: Ocular vascular disease expert joins Eyetech

New York-Anthony P. Adamis, MD, an associate professor at Harvard Medical School, has joined Eyetech Pharmaceuticals Inc. as senior vice president of research and chief scientific officer.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Latest CME